Takara Bio Europe and TET Systems are hosting a series of webinars on Tet technology in December.
The webinar series aims to provide additional insights into how to best use the Tet technology for controlling gene expression in eukaryotes.
Tet technology consists of a chimeric transactivator protein and a Tet-specific promoter which the transactivator binds to in response to the presence (Tet-On) or absence (Tet-Off) of the tetracycline analogue doxycycline.
The Tet systems turn the expression of a gene of interest on or off at will, in a dose-dependent and reversible manner.
In particular, the fully reversible nature of the Tet technology has enabled breakthrough insights into mechanisms of learning in animals by the Kandel group, and in the field of oncology.
Other recent applications include the expression of inhibitory RNAs, and inducible pluripotent stem cells.
Webinars include:
Tuesday December 11, 4 pm CET
Tet System: selected applications
Dr. Manfred Gossen, BCRT, Berlin, Germany
Wednesday December 12, 4 pm CET
Getting started with Tet-induced gene expression - Choosing the right system for your application
Dr. Michael Elser, Product Manager, Clontech/Takara Bio Europe, France
